Menlo Therapeutics' Series A Round

Menlo Therapeutics raised a round of funding on August 19, 2013.

Menlo Therapeutics, formerly Tigercat Pharma, is a clinical stage pharmaceutical company dedicated to the development of serlopitant, a once-daily oral NK-1 receptor antagonist, for the treatment of c…

Articles about Menlo Therapeutics' Series A Round: